In this report, the Asia-Pacific Plasma Protein Therapeutics market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Plasma protein therapeutics are unique biologics that are used in the replacement therapies for the treatment of medical conditions such as deficiency of a coagulation factor in the hemostasis. Fibrinogen is plasma protein therapeutics used as replacement therapy for treating hemorrhagic diathesis in various diseases such as a fibrinogenemia, dysfibrinogenemia, and hypofibrinogenemia.
Increasing demand for advanced therapies coupled with the rise in the R & D activities for developing novel therapies is expected to augment the market growth of the Asia Pacific plasma protein therapeutics. Growth in the geriatric population in the Asia Pacific region is contributing to various chronic diseases such as cardiovascular and neurological diseases is further expected to foster the market growth plasma protein therapeutics. According to the United Nations Population Fund, by 2050, one in four people in Asia and the Pacific will be over 60 years old. The population of older persons (aged over 60) in the region will triple between 2010 and 2050, reaching close to 1.3 billion people.
The growing focus of the manufacturer on the development of innovative plasma-derived products is also expected to augment the market growth of the Asia Pacific plasma protein therapeutics. The rising popularity of the Immunoglobulins (IG), plasma-derived factor VIII, for treating various diseases is again expected to accelerate the market growth. Growing hemophilia patients in the region are expected to have a positive impact on the market of the Asia Pacific plasma protein therapeutics.
Expanding clinical applications of immunoglobulins coupled with the availability of the well-established facility for storage and maintaining of the plasma protein therapeutics is expected to foster the market growth of the over the forecast timeframe. Moreover, increasing adoption of such novel therapies along with the growing spending on the health infrastructure is further estimated to augment the market growth of the Asia Pacific plasma protein therapeutics. According to Invest India, the hospital industry in India, accounting for 80% of the total healthcare market, is witnessing a huge investor demand from both global as well as domestic investors. The hospital industry is expected to reach $132 bn by 2023 from $ 61.8 bn in 2017; growing at a CAGR of 16-17%. Furthermore, the growing Indian medical tourism market is also expected to stimulate the market growth of Asia Pacific plasma protein therapeutics. According to the India Brand Equity Foundation, the Indian medical tourism market is growing at the rate of 18 percent and is expected to reach US$ 9 billion by 2020.
Geographically, this report split Asia-Pacific into several key Regions, with sales (M Units), revenue (Million USD), market share and growth rate of Plasma Protein Therapeutics for these regions, from 2014 to 2025 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia
Asia-Pacific Plasma Protein Therapeutics market competition by top manufacturers/players, with Plasma Protein Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
On the basis of product, this report displays the sales volume (M Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Coagulation Factor
Immune Globulin
Albumin
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (M Units), market share and growth rate of Plasma Protein Therapeutics for each application, includin
Hemophilia
PID
Other
Table of Contents
Asia-Pacific Plasma Protein Therapeutics Market Report 2019
1 Plasma Protein Therapeutics Overview
1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Classification of Plasma Protein Therapeutics by Product Category
1.2.1 Asia-Pacific Plasma Protein Therapeutics Market Size (Sales) Comparison by Types (2014-2024)
1.2.2 Asia-Pacific Plasma Protein Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Coagulation Factor
1.2.4 Immune Globulin
1.2.5 Albumin
1.2.6 Other
1.3 Asia-Pacific Plasma Protein Therapeutics Market by Application/End Users
1.3.1 Asia-Pacific Plasma Protein Therapeutics Sales (Volume) and Market Share Comparison by Applications (2014-2024)
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Other
1.4 Asia-Pacific Plasma Protein Therapeutics Market by Region
1.4.1 Asia-Pacific Plasma Protein Therapeutics Market Size (Value) Comparison by Region (2014-2024)
1.4.2 China Status and Prospect (2014-2024)
1.4.3 Japan Status and Prospect (2014-2024)
1.4.4 South Korea Status and Prospect (2014-2024)
1.4.5 Taiwan Status and Prospect (2014-2024)
1.4.6 India Status and Prospect (2014-2024)
1.4.7 Southeast Asia Status and Prospect (2014-2024)
1.4.8 Australia Status and Prospect (2014-2024)
1.5 Asia-Pacific Market Size (Value and Volume) of Plasma Protein Therapeutics (2014-2024)
1.5.1 Asia-Pacific Plasma Protein Therapeutics Sales and Growth Rate (2014-2024)
1.5.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Growth Rate (2014-2024)
2 Asia-Pacific Plasma Protein Therapeutics Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Plasma Protein Therapeutics Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Plasma Protein Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Plasma Protein Therapeutics (Volume and Value) by Type
2.2.1 Asia-Pacific Plasma Protein Therapeutics Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Plasma Protein Therapeutics (Volume) by Application
2.4 Asia-Pacific Plasma Protein Therapeutics (Volume and Value) by Region
2.4.1 Asia-Pacific Plasma Protein Therapeutics Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Market Share by Region (2014-2019)
3 China Plasma Protein Therapeutics (Volume, Value and Sales Price)
3.1 China Plasma Protein Therapeutics Sales and Value (2014-2019)
3.1.1 China Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
3.1.2 China Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
3.1.3 China Plasma Protein Therapeutics Sales Price Trend (2014-2019)
3.2 China Plasma Protein Therapeutics Sales Volume and Market Share by Type
3.3 China Plasma Protein Therapeutics Sales Volume and Market Share by Application
4 Japan Plasma Protein Therapeutics (Volume, Value and Sales Price)
4.1 Japan Plasma Protein Therapeutics Sales and Value (2014-2019)
4.1.1 Japan Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
4.1.3 Japan Plasma Protein Therapeutics Sales Price Trend (2014-2019)
4.2 Japan Plasma Protein Therapeutics Sales Volume and Market Share by Type
4.3 Japan Plasma Protein Therapeutics Sales Volume and Market Share by Application
5 South Korea Plasma Protein Therapeutics (Volume, Value and Sales Price)
5.1 South Korea Plasma Protein Therapeutics Sales and Value (2014-2019)
5.1.1 South Korea Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Plasma Protein Therapeutics Sales Price Trend (2014-2019)
5.2 South Korea Plasma Protein Therapeutics Sales Volume and Market Share by Type
5.3 South Korea Plasma Protein Therapeutics Sales Volume and Market Share by Application
6 Taiwan Plasma Protein Therapeutics (Volume, Value and Sales Price)
6.1 Taiwan Plasma Protein Therapeutics Sales and Value (2014-2019)
6.1.1 Taiwan Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Plasma Protein Therapeutics Sales Price Trend (2014-2019)
6.2 Taiwan Plasma Protein Therapeutics Sales Volume and Market Share by Type
6.3 Taiwan Plasma Protein Therapeutics Sales Volume and Market Share by Application
7 India Plasma Protein Therapeutics (Volume, Value and Sales Price)
7.1 India Plasma Protein Therapeutics Sales and Value (2014-2019)
7.1.1 India Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
7.1.2 India Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
7.1.3 India Plasma Protein Therapeutics Sales Price Trend (2014-2019)
7.2 India Plasma Protein Therapeutics Sales Volume and Market Share by Type
7.3 India Plasma Protein Therapeutics Sales Volume and Market Share by Application
8 Southeast Asia Plasma Protein Therapeutics (Volume, Value and Sales Price)
8.1 Southeast Asia Plasma Protein Therapeutics Sales and Value (2014-2019)
8.1.1 Southeast Asia Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Plasma Protein Therapeutics Sales Price Trend (2014-2019)
8.2 Southeast Asia Plasma Protein Therapeutics Sales Volume and Market Share by Type
8.3 Southeast Asia Plasma Protein Therapeutics Sales Volume and Market Share by Application
9 Australia Plasma Protein Therapeutics (Volume, Value and Sales Price)
9.1 Australia Plasma Protein Therapeutics Sales and Value (2014-2019)
9.1.1 Australia Plasma Protein Therapeutics Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Plasma Protein Therapeutics Revenue and Growth Rate (2014-2019)
9.1.3 Australia Plasma Protein Therapeutics Sales Price Trend (2014-2019)
9.2 Australia Plasma Protein Therapeutics Sales Volume and Market Share by Type
9.3 Australia Plasma Protein Therapeutics Sales Volume and Market Share by Application
10 Asia-Pacific Plasma Protein Therapeutics Players/Suppliers Profiles and Sales Data
10.1 Shire (Baxalta)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 CSL
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Grifols
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Octapharma
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Kedrion
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 LFB Group
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Biotest
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 BPL
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
10.9 RAAS
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.9.4 Main Business/Business Overview
10.10 CBPO
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Plasma Protein Therapeutics Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
10.10.4 Main Business/Business Overview
10.11 Hualan Bio
10.12 Kamada
11 Plasma Protein Therapeutics Manufacturing Cost Analysis
11.1 Plasma Protein Therapeutics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Plasma Protein Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2018
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Plasma Protein Therapeutics Market Forecast (2019-2024)
15.1 Asia-Pacific Plasma Protein Therapeutics Sales Volume, Revenue and Price Forecast (2019-2024)
15.1.1 Asia-Pacific Plasma Protein Therapeutics Sales Volume and Growth Rate Forecast (2019-2024)
15.1.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2019-2024)
15.1.3 Asia-Pacific Plasma Protein Therapeutics Price and Trend Forecast (2019-2024)
15.2 Asia-Pacific Plasma Protein Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.1 Asia-Pacific Plasma Protein Therapeutics Sales Volume and Growth Rate Forecast by Region (2019-2024)
15.2.2 Asia-Pacific Plasma Protein Therapeutics Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.3 China Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.4 Japan Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.5 South Korea Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.6 Taiwan Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.7 India Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.8 Southeast Asia Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.9 Australia Plasma Protein Therapeutics Sales, Revenue and Growth Rate Forecast (2019-2024)
15.3 Asia-Pacific Plasma Protein Therapeutics Sales, Revenue and Price Forecast by Type (2019-2024)
15.3.1 Asia-Pacific Plasma Protein Therapeutics Sales Forecast by Type (2019-2024)
15.3.2 Asia-Pacific Plasma Protein Therapeutics Revenue Forecast by Type (2019-2024)
15.3.3 Asia-Pacific Plasma Protein Therapeutics Price Forecast by Type (2019-2024)
15.4 Asia-Pacific Plasma Protein Therapeutics Sales Forecast by Application (2019-2024)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
Request Discount 
Inquire Before Buy
